Exact Sciences Corp.

EXAS

$126.57

+51.22% (1 year change)

Avg closing price

Price range

Market Cap

$20.6 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$408 Million

Total revenue in the last quarter.

Net Income

-$220 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

-$2.27

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-61.76x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$6.33 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

0

The number of full time employees.

Revenue & Earnings

Balance Sheet

News

Exact Sciences Drops on Earnings Loss, Lack of Visibility

Exact Sciences Drops on Earnings Loss, Lack of Visibility

Exact Sciences swung to a large fourth quarter loss due in part to its purchase of Base Genomics.

The Street The Street, 15 days ago
Exact Sciences Announces Fourth Quarter 2020 Results

Exact Sciences Announces Fourth Quarter 2020 Results

MADISON, Wis., Feb. 16, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $466.3 million for the fourth quarter ended Dec. 31, 2020 and ...

PR Newswire PR Newswire, 16 days ago
Leerink Partners Stick to Their Buy Rating for Exact Sciences Corp. By Investing.com

Leerink Partners Stick to Their Buy Rating for Exact Sciences Corp. By Investing.com

Leerink Partners Stick to Their Buy Rating for Exact Sciences Corp.

Investing.com Investing.com, about 1 month ago